Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.

International guidelines recommend surgical revascularisation for unprotected left main (ULM) coronary artery disease. The introduction of drug-eluting stents (DES) as an emergency therapy has resulted in increasing numbers of patients having stents placed in ULM. As a consequence, important data on...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Caterina, A, Cuculi, F, Banning, A
Formato:	Journal article
Lenguaje:	English
Publicado:	2013

Ejemplares similares

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
por: Porto, I, et al.
Publicado: (2005)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
por: Chengbin Zheng, et al.
Publicado: (2019-01-01)

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
por: Schrale, R, et al.
Publicado: (2007)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
por: Mohammad Saifur Rohman, et al.
Publicado: (2023-07-01)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
por: Blackman, D, et al.
Publicado: (2004)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
por: Blackman, D, et al.
Publicado: (2003)

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
por: Stone, GW, et al.
Publicado: (2016)

Paclitaxel eluting stents versus bare metal stents restenosis
por: Ronald Aroche Aportela, et al.
Publicado: (2021-12-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
por: Omar A. Meelu, MS, et al.
Publicado: (2017-03-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
por: Negar Faramarzi, et al.
Publicado: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
por: Sohila Refahi, et al.
Publicado: (2019-03-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
por: Jianbing Zhang, et al.
Publicado: (2025-01-01)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
por: Birong Liu, et al.
Publicado: (2024-12-01)

Risk assessment score for drug eluting stent restenosis
por: Z. A. Gabbasov, et al.
Publicado: (2018-09-01)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Mirco Cosottini, et al.
Publicado: (2010-01-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
por: Juan Wang, et al.
Publicado: (2025-01-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
por: N. G. Veselovskaya, et al.
Publicado: (2014-09-01)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Wansong Hu, et al.
Publicado: (2022-09-01)

Stents versus bypass grafting for left main coronary artery disease.
por: Arnold, JR, et al.
Publicado: (2008)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
por: Abizaid, A, et al.
Publicado: (2012)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Publicado: (2017-04-01)

Axial deformation during coronary stenting: an extreme case.
por: De Caterina, A, et al.
Publicado: (2012)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Guillaume Marquis-Gravel, et al.
Publicado: (2017-09-01)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Xiao-Zeng Wang, et al.
Publicado: (2015-01-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
por: Kakhaber Etsadashvili, et al.
Publicado: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
por: Yen-Wen Liu, et al.
Publicado: (2021-09-01)

Comparison of Gensini score and SYNTAX score for predicting in-stent restenosis in patients with coronary artery disease and drug-eluting stent implantation
por: Min-Tao Gai, et al.
Publicado: (2025-01-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
por: Yasser Gaber Metwally, et al.
Publicado: (2024-12-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
por: Wenjie Yang, et al.
Publicado: (2025-01-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
por: Hongfei Xi, et al.
Publicado: (2023-03-01)

Association of G22A variant of Adenosine Deaminase gene with coronary in-stent restenosis in coronary artery patients receiving drug-eluting stent
por: Elaheh Moosavi, et al.
Publicado: (2020-12-01)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
por: Yong Zhu, et al.
Publicado: (2021-07-01)

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
por: Kyle Murnaghan, et al.
Publicado: (2022-01-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
por: Alain Guidon, et al.
Publicado: (2008-01-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
por: Ganesh Paramasivam, et al.
Publicado: (2019-11-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
por: Luo Y, et al.
Publicado: (2022-02-01)

Extensive right coronary artery dissection following cutting balloon treatment of in-stent restenosis.
por: Niccoli, G, et al.
Publicado: (2002)

Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials.
por: Ming-duo Zhang, et al.
Publicado: (2014-01-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Wen-Juan Xiu, et al.
Publicado: (2018-01-01)

Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis
por: Lucio Padilla, et al.
Publicado: (2024-08-01)